Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05101252 · ClinicalTrials.gov registry record · NA

Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product

A NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

Completed
Registry status
NA
Development phase
77
Enrollment target
9
Study locations

NCT05101252: Completed NA study of Visual Acuity, sponsored by Johnson & Johnson Vision Care.

NCT05101252 is a NA study of Visual Acuity that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 77 participants, below the 136-participant average among 20 other Visual Acuity trials with a reported enrollment target (43% lower). The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05101252, a NA study of Visual Acuity, has completed, sponsored by Johnson & Johnson Vision Care.

COMPLETED
Registry status
NA
Development phase
77 participants
Enrollment target
9
Study locations

Study Summary

This is a single-masked, two-arm, parallel-group, randomized-controlled, dispensing clinical trial to evaluate the visual performance.

Primary Outcome

Binocular visual acuity was measured on a logMAR (Logarithm of Minimal Angle of Resolution) scale under high luminance high contrast condition. At distance (4 meters), VA is assessed using ETDRS (Early Treatment Diabetic Retinopathy Study) charts; while near (40 cm) and intermediate (64 cm) assessments were made using reduced Guillon-Poling charts. Letter-by-letter results calculated the visual performance score for each chart read. LogMAR scores closer to zero, or below zero, indicate a better

Conditions Studied

Interventions

  • DEVICE senofilcon A C3
  • DEVICE Dailies Total 1 Multifocal Contact Lenses

Study Locations (9)

Florida

  • Stam & Associates Eye Care - Jacksonville
  • Sabal Eye Care - Longwood

Georgia

  • Visual Eyes - Roswell

Kansas

  • Kannarr Eye Care - Pittsburg

Michigan

  • Birmingham Vision Care - Bloomfield Township

New York

  • Eye Associates of New York - New York

Ohio

  • ProCare Vision Centers - Granville

Rhode Island

  • West Bay Eye Associates - Warwick

Texas

  • Tyler Eye Associates - Tyler

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2021-10-11
Est. Completion 2021-11-29
Phase NA
Johnson & Johnson Vision Care

142 total trials

What the finished NCT05101252 record still lists

NCT05101252 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 136-participant average among 20 other Visual Acuity trials with a reported enrollment target (43% lower).

The record links to 1 condition, with Visual Acuity appearing as the primary indexed condition, and to 2 interventions - of which senofilcon A C3 is the first listed.

NCT05101252 lists 9 locations in 8 states (Florida, Georgia, Kansas).

Frequently Asked Questions

What is clinical trial NCT05101252 about?

NCT05101252 is a clinical study titled "Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product". This is a single-masked, two-arm, parallel-group, randomized-controlled, dispensing clinical trial to evaluate the visual performance.

What is the current status of trial NCT05101252?

This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2021-10-11. Estimated completion is 2021-11-29.

What conditions does trial NCT05101252 study?

This clinical trial studies the following conditions: Visual Acuity.

What interventions are being tested in trial NCT05101252?

The interventions under investigation include: senofilcon A C3 (DEVICE), Dailies Total 1 Multifocal Contact Lenses (DEVICE).

Who is sponsoring clinical trial NCT05101252?

This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05101252 being conducted?

This trial has 9 study locations across Florida, Georgia, Kansas, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Visual Acuity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05101252's enrollment target sits among peer trials

77 13th of 20 higher than 8 of 20 other Visual Acuity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Visual Acuity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02127398 · 77 participants · Phase 2

    Stool Transplants to Treat Refractory Clostridium Difficile Colitis

  • NCT04159103 · 77 participants · Phase 1

    Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • NCT04683003 · 77 participants · Phase 3

    A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

  • NCT05004116 · 77 participants · Phase 1

    A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05101252, the US trial registry maintained by the National Library of Medicine. NCT05101252 (small enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.